¼¼°èÀÇ ·Îº¿ ÀÇÁ· ½ÃÀåÀº 2024³â¿¡´Â 12¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, ÀÇÁ· ±â¼ú, ƯÈ÷ ·Îº¿ ¿ëµµÀÇ Áøº¸¿Í À̵¿ º¸Á¶±â ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2034³â¿¡´Â 36¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 11.5%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.
Àα¸ °í·ÉÈ, ¿Ü»ó, ´ç´¢º´, Ç÷°ü ÁúȯÀ¸·Î ÀÎÇÑ ¼Õ½Ç »ç·ÊÀÇ Áõ°¡¿Í °°Àº ¿äÀεµ ½ÃÀå È®ÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
·Îº¿ ÀÇÁ·, ƯÈ÷ ¸¶ÀÌÅ©·ÎÇÁ·Î¼¼¼ Á¦¾î(MPC) ¹× AI ±â¹Ý ¸ðµ¨Àº Çâ»óµÈ ±â´É°ú ÀûÀÀ¼ºÀ» Á¦°øÇÏ¿© »ç¿ëÀÚ°¡ ½±°Ô ¿òÁ÷ÀÏ ¼ö ÀÖ°í Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» ³ôÀÔ´Ï´Ù. ź¼Ò ¼¶À¯ ¹× ƼŸ´½°ú °°Àº °æ·® ¼ÒÀçÀÇ ¹ßÀüÀº ÀÇÁ·ÀÇ °µµ¿Í ³»±¸¼ºÀ» Å©°Ô Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÀç´Â ÀÇÁ· ÀåÄ¡ÀÇ Àü¹ÝÀûÀÎ ¼º´ÉÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ÀÇÁ·À» ´õ Æí¾ÈÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖÀ¸¸ç »ç¿ëÀÚ Ä£ÈÀûÀ¸·Î ¸¸µì´Ï´Ù. ÀÌ·¯ÇÑ Àç·áÀÇ »ç¿ëÀº °µµ¸¦ ÀúÇϽÃŰÁö ¾ÊÀ¸¸é¼ ÀÇÁ·À» °æ·®ÈÇÏ¿© »ç¿ëÀÚ°¡ ÀÚÀ¯·Ó°Ô ¿òÁ÷ÀÏ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ´Â ±â´É¼º°ú Æí¾ÈÇÔÀ» ¸ðµÎ ÃæÁ·½ÃŰ´Â ÀÇÁ· ¼Ö·ç¼ÇÀ» ã´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀ» È®´ë½Ã۰í ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 12¾ï ´Þ·¯ |
¿¹Ãø ±Ý¾× | 36¾ï ´Þ·¯ |
CAGR | 11.5% |
½ÃÀåÀº ±â¼ú ¹× ½Åü ºÎÀ§ ºÐ·ù¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¹üÁÖ·Î ºÐ·ùµÇ¸ç, °¢ ¹üÁÖ´Â ¼ºÀå ÃËÁø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¸¶ÀÌÅ©·ÎÇÁ·Î¼¼¼ Á¦¾î(MPC) ÀÇÁ· ºÎ¹®Àº 11.2%ÀÇ CAGR·Î »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. MPC ÀÇÁ·Àº ±ÕÇü °³¼±, ¿¡³ÊÁö °ü¸® Çâ»ó, ÀûÀÀ¼º °È µî ´Ù¾çÇÑ ÀåÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº »ç¿ëÀÚ°¡ ´õ ÀÚ¿¬½º·´°Ô ¿òÁ÷ÀÌ°í µ¶¸³¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇϸç, ÀÌ´Â °í±Þ À̵¿¼º ¼Ö·ç¼ÇÀ» ã´Â Àý´Ü ȯÀÚµéÀÌ MPC ±â¼úÀ» Á¡Á¡ ´õ ¼±È£ÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.
¶Ç ´Ù¸¥ Áß¿äÇÑ ºÎ¹®ÀÎ ÇÏü ÀÇÁ· ½ÃÀåÀº 11.4%ÀÇ CAGR·Î °ÇÑ ¼ºÀåÀÌ ¿¹»óµÇ¸ç, 2034³â±îÁö 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ÀÌ ºÎ¹®¿¡´Â »çÁö »ó½Ç ÈÄ ¿òÁ÷ÀÓ°ú ±ÕÇüÀ» ȸº¹ÇÏ´Â µ¥ ÇʼöÀûÀÎ ·Îº¿ ¹«¸°ú ¹ß¸ñÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀÇÁ· ÀåÄ¡´Â »ç¿ëÀÚÀÇ º¸Çà, ´Þ¸®±â, Àå½Ã°£ ¼ ÀÖ´Â ´É·ÂÀ» Çâ»ó½ÃÄÑ Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» Å©°Ô °³¼±ÇÕ´Ï´Ù. ÇÏü ÀÇÁ·Àº ÀÚÀ²¼º°ú À̵¿¼ºÀ» ȸº¹ÇÔÀ¸·Î½á °³ÀÎÀÌ ´õ Ȱµ¿ÀûÀ̰í Ãæ½ÇÇÑ »îÀ» ¿µÀ§ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
¹Ì±¹ÀÇ ·Îº¿ ÀÇÁ· ½ÃÀåÀº 2024³â 4¾ï 9,980¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, ÀÌ´Â ±¹°¡ÀÇ Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó¿Í »ó´çÇÑ ÀÇ·á ÁöÃâ¿¡ ±âÀÎÇÕ´Ï´Ù. ¹Ì±¹Àº »çÁö Àý´Ü ȯÀÚ Àα¸°¡ ¸¹¾Æ °í±Þ ÀÇÁ· ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±¹°¡ÀÇ ¿¬±¸ ÀÚ±Ý Áö¿ø°ú ÀÇÁ· ºÐ¾ß¿¡¼ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº ¹Ì±¹À» ±Û·Î¹ú ½ÃÀå ¸®´õ·Î ÀÚ¸®¸Å±èÇÏ°Ô ÇßÀ¸¸ç, ÀÌ´Â °íǰÁú Çõ½ÅÀû ·Îº¿ ÀÇÁ· ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Axile Bionics, Brain Robotics, Blachford Group µî ¼¼°è ·Îº¿ ÀÇÁ· ¾÷°èÀÇ À¯·ÂÇÑ ±â¾÷Àº ½ÃÀå¿¡¼ÀÇ ÁöÀ§¸¦ °ÈÇϱâ À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Ottobock°ú Fillauer LLC´Â ´õ °¡º¿ì¸ç ³»±¸¼ºÀÌ ¶Ù¾î³ ÀÇÁ· Àç·á °³¹ßÀ» À§ÇØ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡¿ÍÀÇ Çù¾÷°ú Á¤ºÎ ÀÚ±Ý Áö¿øÀº Motorica¿Í Myomo¿Í °°Àº ±â¾÷µéÀÌ Á¦Ç°À» °³¼±ÇÏ°í ½ÃÀå Á¡À¯À²À» È®´ëÇÏ´Â µ¥ ±â¿©Çß½À´Ï´Ù. ¶ÇÇÑ º¸Çè»ç ¹× ÀÇ·á ±â°ü°úÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº ·Îº¿ ÀÇÁ·ÀÇ Á¢±Ù¼ºÀ» È®´ëÇØ ÇÊ¿ä·Î ÇÏ´Â »ç¶÷µé¿¡°Ô ´õ ³Î¸® Á¦°øµÇµµ·Ï µ½°í ÀÖ½À´Ï´Ù.
The Global Robotic Prosthetics Market was valued at USD 1.2 billion in 2024 and is estimated to grow at a CAGR of 11.5% to reach USD 3.6 billion by 2034, driven by advancements in prosthetic technology, especially robotic applications, and the increasing demand for mobility aids. Factors like an aging population, rising instances of loss due to trauma, diabetes, and vascular diseases are also fueling market expansion.
Robotic prosthetics, particularly microprocessor-controlled (MPC) and AI-driven models, offer improved functionality and adaptability, allowing users to move with ease and increasing the overall quality of life. The advancement of lightweight materials such as carbon fiber and titanium has significantly contributed to improving the strength and durability of prosthetics. These materials not only enhance the overall performance of prosthetic devices but also make them more comfortable, reliable, and user-friendly. The use of such materials ensures that the prosthetics are lightweight without compromising on strength, enabling users to move freely and with ease. This has expanded the market, as more individuals seek prosthetic solutions that cater to both functionality and comfort.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $1.2 Billion |
Forecast Value | $3.6 Billion |
CAGR | 11.5% |
The market is segmented into various categories, including technology and body part classifications, each playing a crucial role in driving growth. The microprocessor-controlled (MPC) prosthetics segment, for instance, is expected to witness considerable growth, with a projected CAGR of 11.2%. By 2034, this segment is anticipated to reach USD 2.6 billion in market value. MPC prosthetics offer substantial benefits, such as improved balance, better energy management, and enhanced adaptability. These features empower users to move more naturally and maintain greater independence, which makes MPC technology increasingly popular among amputees seeking advanced mobility solutions.
Another important segment, lower body prosthetics, is also set for strong growth, with a forecasted CAGR of 11.4%, reaching USD 2.3 billion by 2034, includes robotic knees and ankles, which play an essential role in restoring movement and balance following limb loss. These prosthetic devices are crucial for improving a user's ability to walk, run, and stand for longer periods, significantly enhancing their overall quality of life. By restoring autonomy and mobility, lower body prosthetics help individuals lead more active and fulfilling lives.
United States Robotic Prosthetics Market was valued at USD 499.8 million in 2024 due to the country's well-established healthcare infrastructure and substantial healthcare spending. The U.S. has a significant population of amputees, contributing to the rising demand for advanced prosthetic technologies. The nation's commitment to research funding and the continuous technological advancements in the field of prosthetics have positioned it as a global leader in the market. This has further fueled the demand for high-quality, innovative robotic prosthetic solutions.
Prominent players in the Global Robotic Prosthetics Industry, such as Axile Bionics, Brain Robotics, and Blatchford Group, are adopting various strategies to strengthen their market positions. These companies focus on continuous technological innovation, with an emphasis on improving the functionality, comfort, and affordability of robotic prosthetics. For instance, Ottobock and Fillauer LLC invest in R&D to develop lighter, more durable prosthetic materials. Collaborations with healthcare professionals and government funding have allowed companies like Motorica and Myomo to refine their products and expand their market share. Additionally, strategic partnerships with insurance providers and healthcare organizations are helping companies ensure wider accessibility of robotic prosthetics to those in need.